Table 2.
Baseline Demographics for Patients in Simvastatin and Placebo Groups
| Baseline Criteria | Simvastatin | Placebo | P Value |
|---|---|---|---|
| Age (yrs) | 44.4 ± 7.8 | 48.3 ± 11.2 | 0.264 |
| Female gender, n (%) | 10 (62.5) | 10 (62.5) | 1.000 |
| Duration of uveitis, (yrs) | 6.8 ± 4.7 | 10.8 ± 9.3 | 0.135 |
| Bilateral disease, n (%) | 13 (81.3) | 15 (91.8) | 0.600 |
| Anatomic location, n (%) | |||
| Intermediate uveitis | 8 (50) | 6 (37.5) | |
| Posterior uveitis | 3 (18.8) | 3 (18.8) | 0.894 |
| Panuveitis | 5 (31.3) | 7 (43.8) | |
| Associated systemic disease, n (%) | 7 (43.8) | 3 (18.8) | 0.127 |
| Prednisolone dose (mg) | 15 ± 8.7 | 16.7 ± 9.5 | 0.505 |